Zager, JS; Orloff, MM; Ferrucci, PF; Choi, JS; Eschelman, DJ; Glazer, ES; Ejaz, A; Richtig, E; Ochsenreither, S; Reddy, SA; Lowe, MC; Beasley, G; Gesierich, AH; Gschnell, M; Dummer, R; Arance, AM; Fenwick, SW; John, J; Wheater, M; Ottensmeier, CHH.
Melphalan/hepatic delivery system versus best available care in patients with unresectable metastatic uveal melanoma: Randomized FOCUS trial results
J CLIN ONCOL. 2024; 42(16):-ASCO 2024, Annual Meeting; Mai 31 - Juni 4, 2024; Chicago, USA.
[Poster]
Web of Science